Filter Results:
(1,247)
Show Results For
- All HBS Web (1,247)
- Faculty Publications (379)
Show Results For
- All HBS Web (1,247)
- Faculty Publications (379)
- 2014
- Working Paper
Eclipsed and Confounded Identities: When High-Status Affiliations Impede Organizational Growth
By: Daniel Malter
I propose that an organization's growth potential may suffer if its identity is eclipsed by or confounded with the organizations with which it collaborates and competes. Using status as a salient feature of identity, I devise two network measures to capture the degree... View Details
Keywords: Distinctiveness; Status; Networks; Resource Acquisition; Growth; Venture Capital; Status and Position; Organizational Change and Adaptation; Identity; Growth and Development Strategy
Malter, Daniel. "Eclipsed and Confounded Identities: When High-Status Affiliations Impede Organizational Growth." Harvard Business School Working Paper, No. 15-019, October 2014.
- Web
Class Profile - Doctoral
students in our doctoral programs have strong quantitative and analytical skills, as demonstrated by their records of academic performance and test scores. 7 PHD Programs 852 Applicants, 2024 4 % Admit rate, 2024 120 Students enrolled 53... View Details
- June 11, 2021
- Article
Addressing Demographic Disparities in Clinical Trials
By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing... View Details
Giusti, Kathy, Richard G. Hamermesh, and Mark Krasnow. "Addressing Demographic Disparities in Clinical Trials." Harvard Business Review Digital Articles (June 11, 2021).
- 07 Jul 2022
- HBS Case
How a Multimillion-Dollar Ice Cream Startup Melted Down (and Bounced Back)
flourishes in Brooklyn In summer 2010, Smith and Cuscuna got serious about selling their homemade ice cream. They opened a pushcart during a neighborhood arts festival, where they could test flavors with the public—a smart move, says... View Details
Keywords: by Pamela Reynolds
- 22 Apr 2008
- First Look
First Look: April 22, 2008
work, we look at the gold standard era (1880-1914) as a "natural experiment" to test whether adoption of a rule-based monetary framework such as the gold standard increased policy credibility. On the basis of the largest... View Details
Keywords: Martha Lagace
- 16 Nov 2016
- Research & Ideas
Turning One Thousand Customers into One Million
First 1,000 Customers, we explored how these two-sided platforms got their start and attracted a significant number of early adopters based on a Harvard Business School case that professor Teixeira wrote with Morgan Brown. “Airbnb maintained a culture of View Details
- September 2014
- Case
Pfizer's Centers for Therapeutic Innovation (CTI)
By: Gary Pisano, James Weber and Kait Szydlowski
In 2010, Pfizer established four small research units in New York, Boston, San Francisco, and San Diego located close to several premier Academic Medical Centers (AMCs), or hospitals with adjoining medical schools. The goal of these units was to redesign collaboration... View Details
Keywords: Drug Development; Academic Collaboration; Research And Development; Innovation; Translational Research; Management; Operations; Problems and Challenges; Research; Science; Information Technology; Strategy; Biotechnology Industry; Pharmaceutical Industry; North and Central America; Europe; Asia
Pisano, Gary, James Weber, and Kait Szydlowski. "Pfizer's Centers for Therapeutic Innovation (CTI)." Harvard Business School Case 615-024, September 2014.
- 23 May 2007
- Working Paper Summaries
What Causes Industry Agglomeration? Evidence from Coagglomeration Patterns
- Web
Technology & Operations Management - Faculty & Research
attention from other social domains whose performance suffers. We test this theory by examining tradeoffs global supply chain factories make when responding to local worker activism, evidenced by varying compliance with multinational... View Details
- June 2020
- Article
Parallel Play: Startups, Nascent Markets, and the Effective Design of a Business Model
By: Rory McDonald and Kathleen Eisenhardt
Prior research advances several explanations for entrepreneurial success in nascent markets but leaves a key imperative unexplored: the business model. By studying five ventures in the same nascent market, we develop a novel theoretical framework for understanding how... View Details
Keywords: Search; Legitimacy; Organizational Innovation; Organizational Learning; Mechanisms And Processes; Institutional Entrepreneurship; Qualitative Methods; Business Model Design; Business Model; Business Startups; Entrepreneurship; Emerging Markets; Adaptation; Competition; Strategy
McDonald, Rory, and Kathleen Eisenhardt. "Parallel Play: Startups, Nascent Markets, and the Effective Design of a Business Model." Administrative Science Quarterly 65, no. 2 (June 2020): 483–523.
- August 2013
- Article
Customer-Driven Misconduct: How Competition Corrupts Business Practices
By: Victor Manuel Bennett, Lamar Pierce, Jason A. Snyder and Michael W. Toffel
Competition among firms yields many benefits but can also encourage firms to engage in corrupt or unethical activities. We argue that competition can lead organizations to provide services that customers demand but that violate government regulations, especially when... View Details
Keywords: Competition; Crime and Corruption; Management Practices and Processes; Ethics; Consumer Behavior; Customer Satisfaction; Auto Industry; Service Industry
Bennett, Victor Manuel, Lamar Pierce, Jason A. Snyder, and Michael W. Toffel. "Customer-Driven Misconduct: How Competition Corrupts Business Practices." Management Science 59, no. 8 (August 2013): 1725–1742. (Online Appendix. Lead article. Nominated for "Best Conference Paper Award" and "SMS Best Conference Paper Prize for Practice Implications" at 2012 Strategic Management Society International Conference.)
- August 2023 (Revised May 2024)
- Case
Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
The success or failure of Dicerna Pharmaceuticals (Dicerna) as an emerging pharmaceutical company would likely hinge on its lead drug candidate Nedosiran and the company’s ability to see it successfully through clinical development. Ralf Rosskamp, Chief Medical... View Details
Keywords: Business Strategy; Health Testing and Trials; Product Development; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry
Tadikonda, Satish, and Amanda McEwen. "Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations." Harvard Business School Case 824-018, August 2023. (Revised May 2024.)
Best-selling and New Cases by Ben Esty
Best-Selling Cases:
1) Eaton: Portfolio Transformation & Cost of... View Details
- March 2016 (Revised March 2022)
- Teaching Note
Evive Health and Workplace Influenza Vaccinations
By: John Beshears
Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective messages that improve individuals' health... View Details
Keywords: Vaccination; Influenza; Flu Shot; Preventive Care; Health Care; Behavioral Economics; Choice Architecture; Nudge; Experimental Design; Randomized Controlled Trial; RCT; Causal Inference; Health Care and Treatment; Insurance; Health; Consumer Behavior; Health Testing and Trials; Communication Strategy; Insurance Industry; Health Industry
- 12 Jan 2010
- First Look
First Look: Jan. 12
to meet or beat key benchmarks. This paper examines this hypothesis by testing how different types of marketing expenditures are used to boost earnings for a durable commodity consumer product, which can be easily stockpiled by... View Details
Keywords: Martha Lagace
- 05 May 2014
- Research & Ideas
Reflecting on Work Improves Job Performance
simply completed another round of brain teasers. In the reflection condition, participants took a few minutes to reflect on their first round of brain teasers, writing detailed notes about particular strategies they employed. Then they,... View Details
Keywords: by Carmen Nobel
- 16 Oct 2012
- First Look
First Look: October 16
Sonnenberg, Susan J. Barraclough, and Anne N. Thorndike Publication:American Journal of Preventive Medicine 43, no. 1 (September 2012) Abstract Background: Effective strategies are needed to address obesity, particularly among minority... View Details
Keywords: Sean Silverthorne
- Web
Courses - Entrepreneurship
estate developers to inventors. TEM will give students the opportunity to hone their skills in identifying and testing business opportunities, decomposing complex business problems, determining what decisions the responsible business... View Details
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- 2021
- Working Paper
The Origins of CE Marking: Standards, Business, and the European Market in the 1980s–1990s
By: Grace Ballor
Many products—from consumer electronics to machinery to children’s toys—bear the CE Mark, the symbol of conformity to the ‘essential requirements’ of European standards governed by the process of CE Marking. This working paper traces the development of the system of... View Details
Keywords: Business And Government; Market Liberalization; Standards; Markets; Trade; Integration; Business History; Globalization; Business and Government Relations; Europe; European Union
Ballor, Grace. "The Origins of CE Marking: Standards, Business, and the European Market in the 1980s–1990s." Harvard Business School Working Paper, No. 21-142, June 2021.